680 related articles for article (PubMed ID: 17848610)
1. Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991 2005).
Villar E; Chang SH; McDonald SP
Diabetes Care; 2007 Dec; 30(12):3070-6. PubMed ID: 17848610
[TBL] [Abstract][Full Text] [Related]
2. ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.
McDonald SP; Russ GR; Kerr PG; Collins JF;
Am J Kidney Dis; 2002 Dec; 40(6):1122-31. PubMed ID: 12460029
[TBL] [Abstract][Full Text] [Related]
3. The effect of diabetes on incidence and mortality in end-stage renal disease in Germany.
Hoffmann F; Haastert B; Koch M; Giani G; Glaeske G; Icks A
Nephrol Dial Transplant; 2011 May; 26(5):1634-40. PubMed ID: 20959344
[TBL] [Abstract][Full Text] [Related]
4. Perceived health-related quality of life and comorbidity in diabetic patients starting dialysis (CALVIDIA study).
Martínez-Castelao A; Gòrriz JL; Garcia-López F; López-Revuelta K; De Alvaro F; Cruzado JM;
J Nephrol; 2004; 17(4):544-51. PubMed ID: 15372417
[TBL] [Abstract][Full Text] [Related]
5. Geographic, ethnic, age-related and temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific region, 1998-2002.
; Stewart JH; McCredie MR; Williams SM
Nephrol Dial Transplant; 2006 Aug; 21(8):2178-83. PubMed ID: 16595584
[TBL] [Abstract][Full Text] [Related]
6. Increases in renal replacement therapy in Australia and New Zealand: understanding trends in diabetic nephropathy.
Grace BS; Clayton P; McDonald SP
Nephrology (Carlton); 2012 Jan; 17(1):76-84. PubMed ID: 21854505
[TBL] [Abstract][Full Text] [Related]
7. [Pre-occupying increase in diabetes as cause for terminal kidney failure. Evaluation of treatment strategies].
Pérez García R; Rodríguez Benítez P; Dall'Anesse C; Gómez Campderá F; Valderrábano F
An Med Interna; 2001 Apr; 18(4):175-80. PubMed ID: 11496535
[TBL] [Abstract][Full Text] [Related]
8. Renal replacement therapy for diabetic end-stage renal disease. Experience of a Tunisian hospital centre.
Abderrahim E; Zouaghi K; Hedri H; Ben Abdallah T; Ben Hamida F; Kaaroud H; Goucha R; Ben Abdallah N; Khiari K; El Younsi F; Ben Moussa F; Kheder A; Ben Maïz H
Diabetes Metab; 2001 Nov; 27(5 Pt 1):584-90. PubMed ID: 11694858
[TBL] [Abstract][Full Text] [Related]
9. Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study.
Tsakiris DJ; Stel VS; Finne P; Fraser E; Heaf J; de Meester J; Schmaldienst S; Dekker F; Verrina E; Jager KJ
Nephrol Dial Transplant; 2010 Apr; 25(4):1200-6. PubMed ID: 20037169
[TBL] [Abstract][Full Text] [Related]
10. Improved survival of type 2 diabetic patients on renal replacement therapy in Finland.
Kervinen M; Lehto S; Ikäheimo R; Karhapää P; Grönhagen-Riska C; Finne P
Nephrol Dial Transplant; 2010 Mar; 25(3):892-6. PubMed ID: 19846391
[TBL] [Abstract][Full Text] [Related]
11. Divergent trends in the incidence of end-stage renal disease due to Type 1 and Type 2 diabetes in Europe, Canada and Australia during 1998-2002.
; Stewart JH; McCredie MR; Williams SM
Diabet Med; 2006 Dec; 23(12):1364-9. PubMed ID: 17116189
[TBL] [Abstract][Full Text] [Related]
12. Regional and social inequalities in chronic renal replacement therapy in Denmark.
Hommel K; Rasmussen S; Kamper AL; Madsen M
Nephrol Dial Transplant; 2010 Aug; 25(8):2624-32. PubMed ID: 20207710
[TBL] [Abstract][Full Text] [Related]
13. Duration of end-stage renal disease and kidney transplant outcome.
Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
[TBL] [Abstract][Full Text] [Related]
14. Time trends in the epidemiology of renal transplant patients with type 1 diabetes mellitus over the last four decades.
Cao C; Hellermann JP; Weber M; Ambühl PM
Nephrol Dial Transplant; 2006 Mar; 21(3):770-5. PubMed ID: 16401627
[TBL] [Abstract][Full Text] [Related]
15. Patients with diabetic nephropathy on renal replacement therapy in England and Wales.
Nitsch D; Burden R; Steenkamp R; Ansell D; Byrne C; Caskey F; Roderick P; Feest T
QJM; 2007 Sep; 100(9):551-60. PubMed ID: 17681992
[TBL] [Abstract][Full Text] [Related]
16. The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden.
Evans M; Fryzek JP; Elinder CG; Cohen SS; McLaughlin JK; Nyrén O; Fored CM
Am J Kidney Dis; 2005 Nov; 46(5):863-70. PubMed ID: 16253726
[TBL] [Abstract][Full Text] [Related]
17. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
[TBL] [Abstract][Full Text] [Related]
18. End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases.
Tang W; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Clayton PA; Campbell SB; de Zoysa JR; Johnson DW
Nephrol Dial Transplant; 2013 Feb; 28(2):455-61. PubMed ID: 23182810
[TBL] [Abstract][Full Text] [Related]
19. [Has the incidence of end-stage renal disease increased in diabetic patients? A center-based longitudinal study over 10 years].
Van Landeghem MA
Med Klin (Munich); 2005 May; 100(5):241-5. PubMed ID: 15902377
[TBL] [Abstract][Full Text] [Related]
20. Long-term prognosis of patients after kidney transplantation: a comparison of those with or without diabetes mellitus.
Schiel R; Heinrich S; Steiner T; Ott U; Stein G
Nephrol Dial Transplant; 2005 Mar; 20(3):611-7. PubMed ID: 15689368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
